Skip to main content
Presentation
Single agent ONC201 in adult recurrent H3 K27M-mutant glioma.
Journal of Clinical Oncology (2019)
  • Isabel Arrillaga, Harvard University
  • Sylvia Kurz, New York University
  • Ashley Sumrall, Levine Cancer Institute, Charlotte, NC;
  • Nicholas A. Butowski, University of California, San Francisco
  • Rebecca A. Harrison, University of Texas MD Anderson Cancer Center
  • John Frederick De Groot, University of Texas MD Anderson Cancer Center
  • Nicole A. Shonka, University of Nebraska Medical Center
  • Frank S. Lieberman, University of Pittsburgh
  • Yazmin Odia, Baptist Hospital of Miami
  • Rohinton Tarapore, Oncoceutics, Philadelphia, PA;
  • Krystal Merdinger, Oncoceutics, Philadelphia, PA;
  • Joshua E. Allen, Oncoceutics, Philadelphia, PA;
  • Wolfgang Oster, Oncoceutics, Philadelphia, PA;
  • Minesh P. Mehta, Baptist Hospital of Miami
  • Timothy Francis Cloughesy, University of California, Los Angeles
  • Andrew S. Chi, New York University
  • Andrew B. Lassman, Columbia University
  • Tracy Batchelor, Harvard University
  • Patrick Y. Wen, Brigham and Women's Hospital
Publication Date
May 20, 2019
DOI
10.1200/jco.2019.37.15_suppl.3005
Citation Information
Isabel Arrillaga, Sylvia Kurz, Ashley Sumrall, Nicholas A. Butowski, et al.. "Single agent ONC201 in adult recurrent H3 K27M-mutant glioma." Journal of Clinical Oncology (2019)
Available at: http://works.bepress.com/minesh-mehta/392/